Developmental perspectives in pediatric psychopharmacology

B. Vitiello, P. S. Jensen

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Compared with adults, children and adolescents respond to psychotropic madications in some distinctive ways that have implications for both efficacy and safety. Age-related differences in pharmacokinetics and pharmacodynamics account for some of these difference. But while the disposition of several psychotropics in children has been studied, the pharmacodynamic effects of the interaction between the drug and the developing brain are still largely unknown. There is now evidence that the major neurotransmitter systems undergo developmental changes that can extend into the second decade of life. Data from various animal models also show that the administration of psychotropics in the pre- and perinatal period can interfere with the development and produce permanent changes in the neurotransmitter system in question. The extrapolation of these data to humans is difficult. Given the increasing use of psychotropics in the pediatric age, the need emerges for systematic investigation on long-term effects of these dregs on the developing brain.

Original languageEnglish (US)
Pages (from-to)75-81
Number of pages7
JournalPsychopharmacology Bulletin
Volume31
Issue number1
StatePublished - 1995
Externally publishedYes

Fingerprint

Psychopharmacology
Neurotransmitter Agents
Pediatrics
Brain
Drug Interactions
Animal Models
Pharmacokinetics
Safety

Keywords

  • children
  • development
  • psychopharmacology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology

Cite this

Developmental perspectives in pediatric psychopharmacology. / Vitiello, B.; Jensen, P. S.

In: Psychopharmacology Bulletin, Vol. 31, No. 1, 1995, p. 75-81.

Research output: Contribution to journalArticle

Vitiello, B & Jensen, PS 1995, 'Developmental perspectives in pediatric psychopharmacology', Psychopharmacology Bulletin, vol. 31, no. 1, pp. 75-81.
Vitiello, B. ; Jensen, P. S. / Developmental perspectives in pediatric psychopharmacology. In: Psychopharmacology Bulletin. 1995 ; Vol. 31, No. 1. pp. 75-81.
@article{d367d3715c8543aeb3b0633c44d73a2d,
title = "Developmental perspectives in pediatric psychopharmacology",
abstract = "Compared with adults, children and adolescents respond to psychotropic madications in some distinctive ways that have implications for both efficacy and safety. Age-related differences in pharmacokinetics and pharmacodynamics account for some of these difference. But while the disposition of several psychotropics in children has been studied, the pharmacodynamic effects of the interaction between the drug and the developing brain are still largely unknown. There is now evidence that the major neurotransmitter systems undergo developmental changes that can extend into the second decade of life. Data from various animal models also show that the administration of psychotropics in the pre- and perinatal period can interfere with the development and produce permanent changes in the neurotransmitter system in question. The extrapolation of these data to humans is difficult. Given the increasing use of psychotropics in the pediatric age, the need emerges for systematic investigation on long-term effects of these dregs on the developing brain.",
keywords = "children, development, psychopharmacology",
author = "B. Vitiello and Jensen, {P. S.}",
year = "1995",
language = "English (US)",
volume = "31",
pages = "75--81",
journal = "Psychopharmacology Bulletin",
issn = "0048-5764",
publisher = "MedWorks Media LLC",
number = "1",

}

TY - JOUR

T1 - Developmental perspectives in pediatric psychopharmacology

AU - Vitiello, B.

AU - Jensen, P. S.

PY - 1995

Y1 - 1995

N2 - Compared with adults, children and adolescents respond to psychotropic madications in some distinctive ways that have implications for both efficacy and safety. Age-related differences in pharmacokinetics and pharmacodynamics account for some of these difference. But while the disposition of several psychotropics in children has been studied, the pharmacodynamic effects of the interaction between the drug and the developing brain are still largely unknown. There is now evidence that the major neurotransmitter systems undergo developmental changes that can extend into the second decade of life. Data from various animal models also show that the administration of psychotropics in the pre- and perinatal period can interfere with the development and produce permanent changes in the neurotransmitter system in question. The extrapolation of these data to humans is difficult. Given the increasing use of psychotropics in the pediatric age, the need emerges for systematic investigation on long-term effects of these dregs on the developing brain.

AB - Compared with adults, children and adolescents respond to psychotropic madications in some distinctive ways that have implications for both efficacy and safety. Age-related differences in pharmacokinetics and pharmacodynamics account for some of these difference. But while the disposition of several psychotropics in children has been studied, the pharmacodynamic effects of the interaction between the drug and the developing brain are still largely unknown. There is now evidence that the major neurotransmitter systems undergo developmental changes that can extend into the second decade of life. Data from various animal models also show that the administration of psychotropics in the pre- and perinatal period can interfere with the development and produce permanent changes in the neurotransmitter system in question. The extrapolation of these data to humans is difficult. Given the increasing use of psychotropics in the pediatric age, the need emerges for systematic investigation on long-term effects of these dregs on the developing brain.

KW - children

KW - development

KW - psychopharmacology

UR - http://www.scopus.com/inward/record.url?scp=0029126371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029126371&partnerID=8YFLogxK

M3 - Article

C2 - 7675993

AN - SCOPUS:0029126371

VL - 31

SP - 75

EP - 81

JO - Psychopharmacology Bulletin

JF - Psychopharmacology Bulletin

SN - 0048-5764

IS - 1

ER -